AI and automation – sometimes called hyperautomation – are evolving quickly with business consultants emphasizing their rising capacity to function independently and make clever choices.
By combining highly effective generative AI with enterprise experience, organizations can speed up and streamline their processes like by no means earlier than.
I lately sat down with Mayank Anand, Vice President of World Scientific Operations at a number one pharmaceutical firm, to debate the important position AI and automation play in driving innovation whereas sustaining high quality and belief in drug improvement.
The pharmaceutical business is leveraging cutting-edge know-how to hurry up the supply of recent remedies with out compromising transparency or belief. Our dialogue explored key use circumstances together with knowledge cleaning, artificial knowledge, digital twins and pharmacoeconomics – demonstrating how AI and automation are enabling quicker high-quality outcomes.
Nonetheless, these developments don’t change the necessity for expert professionals. As an alternative, they emphasize the significance of equipping people with the experience to use and scale AI and automation successfully.
To dive deeper into the transformative impression of AI in life sciences, watch my full dialog with Mayank right here:
SUBSCRIBE TO THE SAS INSIGHTS NEWSLETTER
